Cart
sales@molnova.com
SF5
CAS No. 34634-22-5
SF5( SF-5 | SF 5 | 2,2-Diphenylethylisothiocyanate )
Catalog No. M27794 CAS No. 34634-22-5
SF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 25MG | 39 | In Stock |
|
| 50MG | 56 | In Stock |
|
| 100MG | 77 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 184 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSF5
-
NoteResearch use only, not for human use.
-
Brief DescriptionSF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.
-
DescriptionSF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.(In Vitro):SF5 shows strong cell survival effect of kidney epithelial cells (93% at a concentration of 2.5 μM).
-
In Vitro——
-
In Vivo——
-
SynonymsSF-5 | SF 5 | 2,2-Diphenylethylisothiocyanate
-
PathwayApoptosis
-
TargetApoptosis
-
Recptorribonucleotide reductase(RR)|Bacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number34634-22-5
-
Formula Weight239.34
-
Molecular FormulaC15H13NS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS=C=NCC(c1ccccc1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Larsen IK, et al. Caracemide, a site-specific irreversible inhibitor of protein R1 of Escherichia coli ribonucleotide reductase. J Biol Chem. 1992 Jun 25;267(18):12627-31.
molnova catalog
related products
-
β-Elemene
β-Elemene is a natural product isolated from Curcuma wenyujin, with an antitumor activity and induce cell apoptosis.β-Elemene significantly inhibited the metastatic capacity of MDR gastric cells in vivo and in vitro.?Mechanistically, β-Elemene regulated MMP-2/9 expression and reversed epithelial-mesenchymal transition.?
-
Pivanex
Pivanex is an orally active HDAC inhibitor and an antimetastatic and antiangiogenic agent. Pivanex downregulates the Bcr-Abl protein and enhances apoptosis.
-
Tafasitamab
Tafasitamab (XmAb5574) is an FC-modified humanized monoclonal antibody targeting the human B-cell surface antigen CD19 for the study of diffuse large B-cell lymphoma.
